The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmer, E. M.
Right arrow Articles by van Seventer, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmer, E. M.
Right arrow Articles by van Seventer, G. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2001, 167: 749-758.
Copyright © 2001 by The American Association of Immunologists

IL-12 Decreases Activation-Induced Cell Death in Human Naive Th Cells Costimulated by Intercellular Adhesion Molecule-1. I. IL-12 Alters Caspase Processing and Inhibits Enzyme Function1

Ellen M. Palmer2,*, Lili Farrokh-Siar{dagger}, Jean Maguire van Seventer2,*,{ddagger} and Gijs A. van Seventer2,3,*,{ddagger}

* Committee on Immunology, and Departments of {dagger} Ophthalmology and Visual Sciences and {ddagger} Pathology, University of Chicago, Chicago, IL 60637

Th cells can receive costimulatory signals through the LFA-1/ICAM-1 accessory pathway that are sufficient to induce early Th cell proliferation, but not subsequent cell expansion and maintenance of cell viability. To investigate the regulatory role for IL-12 in ICAM-1-mediated costimulation, human naive Th cells were stimulated with coimmobilized anti-CD3 mAb and ICAM-1 Ig in the presence or absence of IL-12. The ICAM-1-mediated costimulatory signals in this model resulted in early Th cell proliferation followed by cell death that was partially mediated by Fas and involved loss of mitochondrial membrane potential, processing of procaspase-9 and -3, and activation of caspase-3. Addition of IL-12 prevented activation-induced cell death and promoted late proliferation. ICAM-1 + IL-12-costimulated Th cells were resistant to Fas-mediated cell death through a mechanism that did not appear to involve a decrease in either Fas or Fas ligand expression. IL-12 did not inhibit the loss of mitochondrial membrane potential induced by ICAM-1-mediated costimulation, and this finding was consistent with the inability of IL-12 to increase expression of the antiapoptotic Bcl-2 family members, Bcl-2 and Bcl-xL. Interestingly, IL-12 promoted an altered processing of procaspase-9 and -3 and a decrease in the percentage of cells displaying caspase-3 catalytic function. In conclusion, we now describe a novel regulatory function for IL-12 in preventing Th cell death and, as a result, in greatly increasing Th cell viability and expansion. Together, our findings indicate that IL-12 may perform this regulatory role by preventing Fas-mediated activation-induced cell death through inhibition of caspase-3 enzyme activity.




This article has been cited by other articles:


Home page
GutHome page
A. J M Watson
In vivo single-photon emission computed tomography imaging of apoptosis in Crohn's disease and anti-tumour necrosis factor therapy
Gut, April 1, 2007; 56(4): 461 - 463.
[Full Text] [PDF]


Home page
GutHome page
J Mudter and M F Neurath
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications
Gut, February 1, 2007; 56(2): 293 - 303.
[Full Text] [PDF]


Home page
J. Immunol.Home page
H. Riemann, K. Loser, S. Beissert, M. Fujita, A. Schwarz, T. Schwarz, and S. Grabbe
IL-12 Breaks Dinitrothiocyanobenzene (DNTB)-Mediated Tolerance and Converts the Tolerogen DNTB into an Immunogen
J. Immunol., November 1, 2005; 175(9): 5866 - 5874.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Wuthrich, T. Warner, and B. S. Klein
IL-12 Is Required for Induction but Not Maintenance of Protective, Memory Responses to Blastomyces dermatitidis: Implications for Vaccine Development in Immune-Deficient Hosts
J. Immunol., October 15, 2005; 175(8): 5288 - 5297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. G. Feng, D. Jankovic, M. Kullberg, A. Cheever, C. A. Scanga, S. Hieny, P. Caspar, G. S. Yap, and A. Sher
Maintenance of Pulmonary Th1 Effector Function in Chronic Tuberculosis Requires Persistent IL-12 Production
J. Immunol., April 1, 2005; 174(7): 4185 - 4192.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kandula and C. Abraham
LFA-1 on CD4+ T Cells Is Required for Optimal Antigen-Dependent Activation In Vivo
J. Immunol., October 1, 2004; 173(7): 4443 - 4451.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. Nolt and J. L. Flynn
Interleukin-12 Therapy Reduces the Number of Immune Cells and Pathology in Lungs of Mice Infected with Mycobacterium tuberculosis
Infect. Immun., May 1, 2004; 72(5): 2976 - 2988.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Chang, J.-H. Cho, S.-W. Lee, S.-Y. Choi, S.-J. Ha, and Y.-C. Sung
IL-12 Priming during In Vitro Antigenic Stimulation Changes Properties of CD8 T Cells and Increases Generation of Effector and Memory Cells
J. Immunol., March 1, 2004; 172(5): 2818 - 2826.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. S. Seaman, F. W. Peyerl, S. S. Jackson, M. A. Lifton, D. A. Gorgone, J. E. Schmitz, and N. L. Letvin
Subsets of Memory Cytotoxic T Lymphocytes Elicited by Vaccination Influence the Efficiency of Secondary Expansion In Vivo
J. Virol., January 1, 2004; 78(1): 206 - 215.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-J. Ha, D.-J. Kim, K.-H. Baek, Y.-D. Yun, and Y.-C. Sung
IL-23 Induces Stronger Sustained CTL and Th1 Immune Responses Than IL-12 in Hepatitis C Virus Envelope Protein 2 DNA Immunization
J. Immunol., January 1, 2004; 172(1): 525 - 531.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. W. Lee, Y. Park, J. K. Yoo, S. Y. Choi, and Y. C. Sung
Inhibition of TCR-Induced CD8 T Cell Death by IL-12: Regulation of Fas Ligand and Cellular FLIP Expression and Caspase Activation by IL-12
J. Immunol., March 1, 2003; 170(5): 2456 - 2460.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Cleary, W. Tu, A. Enright, T. Giffon, R. Dewaal-Malefyt, K. Gutierrez, and D. B. Lewis
Impaired Accumulation and Function of Memory CD4 T Cells in Human IL-12 Receptor {beta}1 Deficiency
J. Immunol., January 1, 2003; 170(1): 597 - 603.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Takahashi, T. Tashiro, M. Miyazaki, M. Kobayashi, R. B. Pollard, and F. Suzuki
An essential role of macrophage inflammatory protein 1{alpha}/CCL3 on the expression of host's innate immunities against infectious complications
J. Leukoc. Biol., December 1, 2002; 72(6): 1190 - 1197.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Kobayashi, H. Takahashi, A. P. Sanford, D. N. Herndon, R. B. Pollard, and F. Suzuki
An Increase in the Susceptibility of Burned Patients to Infectious Complications Due to Impaired Production of Macrophage Inflammatory Protein 1{alpha}
J. Immunol., October 15, 2002; 169(8): 4460 - 4466.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kwang Yoo, J. Ho Cho, S. Woo Lee, and Y. Chul Sung
IL-12 Provides Proliferation and Survival Signals to Murine CD4+ T Cells Through Phosphatidylinositol 3-Kinase/Akt Signaling Pathway
J. Immunol., October 1, 2002; 169(7): 3637 - 3643.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Y. Park, B. Hondowicz, M. Kopf, and P. Scott
The Role of IL-12 in Maintaining Resistance to Leishmania major
J. Immunol., June 1, 2002; 168(11): 5771 - 5777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.